C&Ckines with differential expression by cytogenetic risk category in AML patients
| C&Ckines . | F statistic . | P . | Relative fold change in expression . | ||
|---|---|---|---|---|---|
| Favorable . | Intermediate . | Unfavorable . | |||
| CCL2 | 4.67 | .011 | 1 | 5 | 6.67 |
| IL-7 | 4.3 | .015 | 3.37 | 1 | 1.39 |
| PDGF-BB | 3.37 | .037 | 1 | 2.7 | 2.03 |
| C&Ckines . | F statistic . | P . | Relative fold change in expression . | ||
|---|---|---|---|---|---|
| Favorable . | Intermediate . | Unfavorable . | |||
| CCL2 | 4.67 | .011 | 1 | 5 | 6.67 |
| IL-7 | 4.3 | .015 | 3.37 | 1 | 1.39 |
| PDGF-BB | 3.37 | .037 | 1 | 2.7 | 2.03 |